Cite
HARVARD Citation
Mizusawa, J. et al. (2023). Protocol of a randomized phase II/III study of gemcitabine plus nab-paclitaxel combination therapy versus modified FOLFIRINOX versus S-IROX for metastatic or recurrent pancreatic cancer: JCOG1611 (GENERATE). Japanese journal of clinical oncology. pp. 80-84. [Online].